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Choice procedures have indicated that the relative reinforcing effectiveness of opioid drugs increases
during opioid withdrawal. The demand curve, an absolute measure of reinforcer value, has not been
applied to this question. The present study assessed whether mild morphine withdrawal would increase
demand for or choice of remifentanil or cocaine. Four rhesus monkeys chose between remifentanil and
cocaine during daily sessions. Demand curves for both drugs were subsequently obtained. The effects of
daily injections of 3.2 mg/kg morphine on both choice and demand for these drugs was assayed 3 and
20.5 hr after each morphine injection, and then during a postmorphine period. Three hours following
morphine injections, choice of remifentanil over cocaine decreased and demand for remifentanil—but
not cocaine—became more elastic. During morphine withdrawal (20.5 hr postinjection), choice of
remifentanil increased and remifentanil demand became more inelastic in 3 of 4 monkeys. Cocaine
demand also became more inelastic during this period. Four to five weeks following the morphine
regimen, demand for both drugs was more inelastic relative to the initial determination. The results
suggest that both the relative and absolute reinforcing effectiveness of remifentanil decreased following
morphine administration and increased during morphine withdrawal. The absolute reinforcing
effectiveness of cocaine also increased during morphine withdrawal. In addition, extended exposure to
drug self-administration and/or exposure to the morphine regimen produced long-term increases in
demand for both drugs.
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rhesus monkeys
_______________________________________________________________________________
Studies of whether the reinforcing effects of
opioids are increased as the result of opioid
withdrawal are important for several reasons.
First, in dependent individuals, opioids may
serve not only as positive reinforcers, but their
self-administration also may be maintained by
negative reinforcement. Opioid withdrawal
has been characterized as an aversive condi-
tion (Downs & Woods, 1975), which is quickly
ameliorated by opioid self-administration
(Gerak, Galici, & France, 2009). Second, there
is the possibility that withdrawal-induced in-
creases in the reinforcing effects of opioids,
particularly if they are long-term, may contrib-
ute to relapse to opioid abuse in recovering
opioid abusers. Two procedures frequently
have been employed to reflect withdrawal-
induced increases in the reinforcing effective-
ness of opioids: the measurement of changes
in rates of responding and number of injec-
tions self-administered, and the measurement
of changes in choice of an opioid over a non-
opioid option.
Gerak et al. (2009) evaluated the effects of
chronic, noncontingent morphine administra-
tion on the self-administration of a range of
heroin and cocaine doses in rhesus monkeys.
Their regimen of twice-daily morphine admin-
istration, which involved increasing the dose of
morphine over a period of several weeks,
resulted in dependence as measured by signs
of withdrawal. Heroin and cocaine self-admin-
istration then was assessed following varying
durations of morphine deprivation. Five hours
after an injection of morphine, rates of
responding maintained by both heroin and
cocaine were decreased relative to baseline.
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However, 17 hr of morphine deprivation led to
increases in the number of injections of small
cocaine doses (less than 10 mg/kg/infusion)
and 29 hr of morphine deprivation led to
increases in the number of injections of all
heroin doses tested (ranging from 5.6 to
560 mg/kg/infusion). Following the comple-
tion of chronic morphine administration, the
number of injections of small heroin doses,
particularly 5.6 mg/kg/infusion and smaller,
remained markedly elevated relative to injec-
tions earned before and during morphine
administration. The authors attributed this
effect to conditioned reinforcement; specifi-
cally, they postulated that the cues paired with
heroin and cocaine infusions became more
effective in maintaining responding during
opioid withdrawal than they had been prior to
morphine exposure. These cues then main-
tained their reinforcing effectiveness for many
weeks following withdrawal.
Studies in rats support this conclusion; for
example, rats trained to self-administer heroin
show marked increases in responding for cues
that were previously paired with heroin. This
occurred for rats that had been heroin
abstinent for 4 weeks as well as for those that
had been heroin abstinent for 1 week (Zhou et
al. 2004).
An alternative evaluation of opioid-main-
tained responding during opioid withdrawal
involves measuring changes in choice of an
opioid versus a non-opioid reinforcer during
opioid withdrawal. Negus (2006) assessed
choice between a range of heroin doses and
food in nondependent and heroin-dependent
rhesus monkeys. At small or zero doses of
heroin, the monkeys showed a near-exclusive
preference for food; as the dose of heroin was
increased, preference shifted from food to
heroin. When the monkeys were given suffi-
cient access to heroin to produce opioid
dependence and were then heroin-restricted,
opioid withdrawal was observed and the choice
of heroin over food was increased substantially
at all but the largest dose.
Earlier findings regarding choice between
heroin and food are consistent with those of
Negus (2006). Griffiths, Wurster, and Brady
(1981) found that infusions of morphine
produced dose-dependent decreases in selec-
tion of heroin over food in baboons whereas
infusions of the opioid antagonist naloxone
produced dose-dependent increases in selec-
tion of heroin. The authors suggested that
morphine and naloxone had altered choice
behavior by interacting with the reinforcing
properties of heroin. Given the large dose of
heroin the baboons obtained (1.0 mg/kg/
injection), it is likely that naloxone produced
increases in choice of heroin in part because it
elicited opioid withdrawal.
Another way to evaluate changes in the
effectiveness of a reinforcer is demand-curve
analysis (e.g., Bickel, DeGrandpre, Higgins, &
Hughes 1990; Hursh & Silberberg, 2008;
Hursh & Winger, 1995). Here, the consump-
tion of a commodity, or reinforcer, is mea-
sured as its price (response requirement) is
altered. Initially as the price (defined here as
the response requirement / dose) of a
reinforcer is increased, consumption is de-
fended by increases in responding and re-
mains relatively unchanged. With further
increases in price, consumption decreases.
When plotted on log–log coordinates, the rate
at which consumption decreases as a function
of price is termed elasticity of demand.
Generally speaking, a reinforcer that is more
effective at maintaining behavior engenders a
less elastic demand curve, with consumption
decreasing at a slower rate as a function of
price, when compared with a reinforcer that is
less effective at maintaining behavior.
In the present experiment, both a choice
procedure and a demand procedure were used
to assess the effects of mild morphine with-
drawal on the reinforcing effectiveness of the
ultrashort-acting m-opioid agonist remifentanil
and the psychostimulant cocaine in rhesus
monkeys. After (premorphine) measures of
choice and demand for cocaine and remifen-
tanil were obtained, 4 monkeys were given
daily injections of 3.2 mg/kg morphine. This
method of morphine administration has been
used previously to produce mild opioid de-
pendence in rhesus monkeys (France &
Woods, 1989; Winger & Woods, 2001). Choice
between cocaine and remifentanil was assessed
for at least 2 weeks in sessions conducted 3 and
20.5 hr after each morphine injection. When
choice of cocaine and remifentanil was stable,
demand for each self-administered drug was
reassessed while daily morphine injections
continued. The morphine injections were
then stopped; 4 to 5 weeks following the final
morphine injection, demand for cocaine and
remifentanil was assessed for a third time. It
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was predicted that, while overall responding
would be suppressed 3 hr following morphine
administration, responding for remifentanil
would be affected to a greater extent than
responding for cocaine at this time. At 20.5 hr
following morphine, choice and demand for
remifentanil was expected to increase relative
to choice and demand for cocaine. It also was
expected that the latter changes would be
maintained, at least to some extent, beyond
the period of daily morphine administration.
METHOD
Subjects
Subjects were 4 adult rhesus monkeys
(Macaca mulatta), 3 male and 1 female. All
monkeys had a history of self-administering
drugs, including cocaine and remifentanil,
according to fixed-ratio (FR) schedules. Ex-
perimental sessions were conducted in the
home cages. The monkeys were fed high-
protein monkey biscuits twice daily and fruit
once daily to maintain their adult body
weights. Water was continuously available and
environmental enrichment was provided on a
rotating basis.
Apparatus
Monkeys were housed and tested in stainless
steel cages that measured 83.3 cm 3 76.2 cm 3
91.4 cm. Each cage was equipped with a
response panel located on the left wall,
approximately 10 cm from the front and
19 cm from the bottom of the cage. The panel
contained three horizontally aligned levers,
each of which could be activated by approxi-
mately 10-15 g of force. Three stimulus lights,
each one of which was centered above a lever,
were 2.5 cm in diameter and spaced 1.5 cm
apart. Each light consisted of a circular
opening that was covered with translucent
plastic and capable of being illuminated from
behind by 5-W colored bulbs.
Monkeys were implanted with an indwelling
intravenous catheter that passed subcutane-
ously from the implanted vein to an exit site
on the monkey’s back. The catheter was fed
through a stainless steel tether that was
attached to the back of the Teflon mesh jacket
(Lomir, Quebec, Canada) worn by each
monkey. The other end of the tether was
attached to the back wall of the cage. Once the
catheter exited the tether at the rear of the
cage, it ultimately was connected to three stock
solutions, one with cocaine, one with remifen-
tanil, and one with saline. The tubing that
connected the catheter with each stock solu-
tion passed through an infusion pump (one
per stock solution) which delivered 0.2 ml of
solution per second. Each delivery lasted 5 s
(totaling a 1-ml injection volume). Control of
experimental sessions was provided by Med-PC
(Med-Associates, Georgia, VT) interfacing and
software (Version IV) installed on computers
located in an adjacent room.
Procedure
Drug-dose selection. The monkeys in the
present experiment were previously employed
in an experiment conducted by Wade-Galuska,
Winger, and Woods (2007). The doses selected
for 3 of the monkeys in the present experi-
ment (30 mg/kg/inf cocaine and 0.3 mg/kg/
inf remifentanil) were based on data obtained
by Wade-Galuska et al. that demonstrated that
these doses maintained comparable levels of
behavior across a variety of response require-
ments. When these doses were used in the
choice phase of the present study, 2 of the 3
monkeys chose remifentanil nearly exclusively.
Therefore, the 4th monkey (3506) was tested
with a smaller dose of remifentanil (0.03 mg/
kg/inf) so that the effects of morphine
administration and deprivation could be ob-
served in an animal that initially preferred
cocaine.
Drug infusions. So that cocaine and remifen-
tanil could be administered within the same
session through the same catheter, the follow-
ing procedure was employed: At the start of
each session, approximately 1 ml saline was
infused into the portion of the catheter
external to the monkey (hereafter, the external
catheter). During each reinforcer delivery, a 10-
s infusion occurred consisting of two compo-
nents. During the first component the drug
pump operated for 5 s, pushing the saline
(infused into the external catheter at the start
of the session) into the monkey while filling
the external catheter with 1 ml of the selected
drug. The second component of an infusion
consisted of the 5-s operation of the saline
pump which pushed the drug into the
monkey, while filling the external catheter
with saline in preparation for the next
reinforcer delivery.
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Drug infusions were characterized by the
same stimulus changes in all phases of the
study. When an infusion was earned, the
stimulus lights above the center and right
levers were turned off and the light above the
left lever turned green for the duration of the
infusion. Following each infusion there was a
45-s timeout in which all stimuli were turned
off and lever presses had no consequence.
Left-lever holding. This procedure, used in
Wade-Galuska et al.’s 2007 experiment as well
as in the present study, was implemented so
that the monkeys could use only one hand,
rather than pressing multiple levers, to select
between the drug options. The procedure
required that monkeys hold down the left
lever (e.g., with the left hand) of the three-
lever panel while completing a response
requirement on another lever (e.g., with the
right hand). At the start of a session, a white
stimulus light above the left lever flashed (0.5 s
on / off) until the left lever was pressed. Once
the lever was pressed, the white stimulus light
above the left lever stopped flashing (turning
solid white) and the stimulus light above the
operative lever turned to the color correlated
with the drug associated with that lever. As
long as the left lever was held down, responses
on the operative lever counted toward com-
pletion of the response requirement. If the
monkey stopped holding the left lever, the
light above the operative drug lever was turned
off and the white light above the left lever
flashed until the left lever was again pressed.
Releasing the left lever suspended the ongoing
schedules, but did not reset the number of
responses already made toward the ratio
requirement.
Premorphine demand. The premorphine de-
mand functions (demand functions obtained
prior to daily morphine injections) for cocaine
and remifentanil were reported in a previous
study conducted by Wade-Galuska et al.
(2007). The same general procedure was used
to generate all demand functions reported in
this experiment, including those obtained by
Wade-Galuska et al. The response requirement
was increased after every two consecutive
sessions according to an ascending sequence
of ratios: 10, 32, 100, 320, 562, and 1000. After
this entire sequence of ratios was tested, two
consecutive sessions at FR 10 followed by two
consecutive sessions at FR 100 were conducted
for each drug for replication purposes. During
premorphine demand only, monkeys were
exposed to a condition in which the center
lever was the operative cocaine lever and
another condition in which the right lever
was the operative cocaine lever. Cocaine was
correlated with a red stimulus light in both
cases; a red light above the operative lever
signaled that completion of the response
requirement would result in a cocaine infu-
sion. Demand also was assessed with remifen-
tanil available for responding on either the
center or right lever across conditions. Remi-
fentanil was correlated with a blue stimulus
light. Each drug was tested on each of the two
levers to ensure that no lever biases existed for
the center or right lever as the result of the
left-lever holding procedure. No biases were
observed, so these conditions were collapsed
across lever-type in order to generate a single
cocaine and remifentanil demand curve con-
sisting of eight sessions at FR 10 and FR 100,
and four sessions at the other ratios. The
average consumption at each ratio was used in
the creation of the premorphine demand
curve. Once morphine injections began and
throughout the remainder of the experiment,
cocaine was associated with the center lever
and remifentanil was associated with the right
lever. Table 1 shows the order in which drugs
were tested when generating demand func-
tions before, during, and after daily morphine
exposure. The order was counterbalanced
Table 1
Order in which drugs were tested in demand conditions
occurring before (Pre), during (Daily), and following






3956 Coc (C) 1 2 –
Coc (R) 4 – –
Remi (C) 3 – –
Remi (R) 2 1 –
3953 Coc (C) 2 1 1
Coc (R) 1 – –
Remi (C) 4 – –
Remi (R) 3 2 2
2084 Coc (C) 2 2 1
Coc (R) 1 – –
Remi (C) 4 – –
Remi (R) 3 1 2
3506 Coc (C) 1 1 2
Coc (R) 2 – –
Remi (C) 3 – –
Remi (R) 4 2 1
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across monkeys and across exposures within
each monkey.
Premorphine choice. Following the completion
of data collection for the experiment reported
by Wade-Galuska et al. (2007) and immediate-
ly prior to the start of daily morphine
injections, 30 mg/kg/inf cocaine and 0.3 mg/
kg/inf remifentanil (or 0.03 mg/kg/inf remi-
fentanil for Monkey 3506) were made available
concurrently. Cocaine was available following
the completion of an FR 10 schedule on the
center lever and remifentanil was available
following the completion of the same response
requirement on the right lever. Under these
circumstances, holding the left lever down
turned on both the red stimulus light above
the center lever and the blue light above the
right lever allowing monkeys to respond for
either drug. The FR 10 response requirement
on one lever did not reset if a response(s)
occurred on the other lever during the
completion of a ratio. The response require-
ment for both drugs was reset only at the start
of a new ratio following an infusion and
subsequent 45-s timeout.
Choice sessions consisted of at least one
lever reversal (two were conducted for Monkey
2084), during which remifentanil was earned
from completing a ratio on the center lever
and cocaine from completing a ratio on the
right lever. The stimulus light color associated
with each drug remained the same as it had
been before. In all cases, preference tracked
the reversal and choice was nearly identical to
that observed prior to the reversal. A return to
standard lever conditions (cocaine available
on the right lever and remifentanil on the
center) followed. Again, preference tracked
this change. Behavior was judged stable
(during the lever reversal and the return to
standard lever conditions) when at least six
sessions were conducted and when no increas-
ing or decreasing trends in choice were
observed. Only data from the last six sessions
of the return to standard lever conditions were
used in the calculation of premorphine
choice.
Daily morphine administration. Once choice
between cocaine and remifentanil was stable,
daily injections of 3.2 mg/kg morphine began.
Each injection was administered i.v. approxi-
mately 3 hr prior to the afternoon session and
20.5 hr prior to the session that occurred the
following morning (recall that sessions were
conducted twice daily, once in the morning
and once in the afternoon). During the period
of daily morphine administration, choice and
demand data were analyzed separately for
sessions occurring at the 3-hr and 20.5-hr time
points.
Choice sessions continued while daily mor-
phine injections were administered. Although
not explicitly quantified, after about 2 weeks of
morphine injections, one or more signs of
mild withdrawal, including increased vocaliza-
tion, salivation, and irritability, were observed
prior to injections. These symptoms typically
were alleviated upon the administration of
morphine, indicating a mild degree of physical
dependence on morphine. Monkeys also
experienced some weight loss over the course
of morphine administration. We concluded
that this was likely due to morphine-induced
decreases in food consumption rather than
withdrawal-induced decreases in appetite be-
cause food consumption generally increased
as the time since the most recent morphine
injection increased (up to the time of the
subsequent injection).
After at least 2 weeks and when choice was
stable in sessions conducted at each time
point, demand functions were again obtained
for cocaine and remifentanil while daily
morphine injections continued. Each ratio
was in effect for two consecutive sessions as
previously described, so that at least one
session was conducted 3 hr after morphine
and one session was conducted 20.5 hr after
morphine at each response requirement. At
least one response requirement (usually 10,
32, or 100) was then replicated. For the
monkey (3506) that was tested with a small
dose of remifentanil (0.03 mg/kg/inf) in
choice sessions, the dose was increased to
0.3 mg/kg/inf because the smaller dose did
not maintain behavior in the context of a
demand procedure.
Postmorphine choice. Following daily mor-
phine administration, Monkey 3956 became
ill for reasons unrelated to the study, and was
euthanized. The remaining monkeys were
returned to the procedure that allowed them
to choose between cocaine and remifentanil.
The remifentanil dose was decreased to
0.03 mg/kg/inf for Monkey 3506 in order to
compare preference before and after daily
morphine administration. Also, Monkey 3953
experienced a catheter failure at the end of
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daily morphine administration and had a 1-
week hiatus and catheter implantation surgery
prior to returning to the choice procedure.
Once she resumed choice at the end of this
hiatus, she responded exclusively for remifen-
tanil. It is believed that this was because her
most recent history was with remifentanil as
the only drug available. Because of this, a lever
reversal was conducted and stable choice (see
Table 2), in which remifentanil was chosen at
premorphine levels (as well as during daily
morphine administration) was again observed.
Approximately 4 to 5 weeks later, demand
was reassessed for each drug (see Table 1 for
the order that drugs were tested) according to
the demand procedure previously described.
All sessions lasted 2 hr and were conducted
twice daily at the same times each day (once in
the morning and once in the afternoon),
7 days per week.
Data Analysis
Demand curves. The exponential demand
equation (Hursh & Silberberg, 2008) was fitted
to the average number of drug deliveries
earned at each response requirement. In this
equation:
log Q~log Q0ð Þzk e{a P {1
 
,
Q represents the number of drug deliveries at
each response requirement, or price (P). Q0 is
an estimate of consumption at zero-price and
mathematically represents the y-intercept. The
parameter k is a scaling parameter represent-
ing the range of the dependent variable in
logarithmic units. We set k at a constant value
of 3 for all analyses because it was the smallest
whole number whose antilog (1000) was
greater than all observed dependent values.
The parameter a provides an index of elasticity
of demand: As a increases, consumption drops
off more quickly with increases in price.
Conversely, smaller values of a reflect more
inelastic functions in which consumption
decreases more slowly with increases in price.
Hursh and Silberberg argued that a provides a
measure of the reinforcing effectiveness of a
commodity. For instance, if opioid withdrawal
increases the reinforcing effectiveness of a self-
administered drug, the a parameter should
decrease.
The graphing and statistical software Prism
(GraphPad Software, Inc., San Diego, CA) was
used in the graphing and statistical analysis of
demand functions. We fitted the exponential
demand function to the individual subject and
group data for each drug and time point: pre,
3 hr, 20.5 hr, and post. In cases in which
monkeys did not earn an injection, a value of
0.1 was assigned because the log of zero is
undefined. We focused on two parameters of
the exponential demand equation: a and Q0.
As described, a represents elasticity of de-
mand. We also analyzed the Q0 parameter as
an index of the initial level of demand because
it is possible that demand curves could shift
vertically without affecting demand elasticity.
For each drug, the values of these parameters,
along with goodness of fit (R2), were obtained
both for the group and individually at each
point of the study.
Response rate. Rates of responding were
calculated for all sessions. However, the left
lever-holding procedure used in the present
experiment required that monkeys hold down
the left lever in order to gain access to the
schedule(s) in effect. Therefore, the time used
in the calculation of response rate was
incremented only when the left lever was
Table 2
The average number of drug infusions earned over the last six stable choice sessions of each
condition, including sessions prior to daily morphine (Pre), sessions occurring 3 and 20.5 hr
following each morphine injection during daily morphine, and sessions conducted 4 to 5 weeks
following daily morphine (Post). Standard deviation is shown in parentheses.
Monkey
Pre 3 hr 20.5 hr Post
Coc Remi Coc Remi Coc Remi Coc Remi
3956 20 (7) 83 (3) 22 (7) 20 (8) 4 (2) 86 (6) – –
3953 19 (7) 86 (3) 10 (4) 82 (7) 10 (3) 96 (3) 31* (5) 80* (3)
2084 34 (3) 48 (5) 44 (15) 15 (4) 14 (4) 101 (6) 48 (9) 54 (11)
3506 88 (2) 4 (3) 70 (9) 7 (8) 36 (10) 22 (7) 68 (7) 4 (3)
* Data based on choice sessions in which levers were reversed. See text for additional details.
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being held down. This time was not incremen-
ted during infusions or during the time spent
in timeout following an infusion, when left-
lever holding had no programmed conse-
quences. Response rates were calculated as
the number of responses divided by the
adjusted session time. This procedure for
calculating rates did not reflect the number
of infusions earned during the demand
procedure, although rates were congruent
with choice in the choice procedure.
RESULTS
Choice
Table 2 shows the average number of
remifentanil and cocaine infusions earned
during stable choice sessions conducted be-
fore (pre), during, and following (post) daily
morphine administration. Prior to the start of
daily morphine injections, 3 of the 4 monkeys
showed a preference for remifentanil, al-
though Monkey 2084 chose remifentanil
much less relative to the other monkeys
(approximately 60% versus 80%; see Figure 1,
unconnected data points above first sessions)
exhibiting this preference. In an attempt to
evaluate the study parameters in a monkey that
initially preferred cocaine, the remifentanil
dose for Monkey 3506 was smaller: 0.03 g/kg/
inf. Under these conditions, this monkey
showed a near- exclusive preference for
cocaine.
During the period of daily morphine injec-
tions, choice of remifentanil varied across
monkeys in the sessions conducted 3 hr
following injections (left panels, Figure 1).
Monkeys 3956 and 2084 both showed about a
50% decrease in their choice of remifentanil
and a corresponding increase in their choice
of cocaine. However, this change in choice was
abrupt for Monkey 2084 and more gradual for
3956. Monkey 3953 showed an initial decrease
in choice of remifentanil from 80% to 60%
over the first 2 days of morphine administra-
tion. Thereafter, choice of remifentanil recov-
ered to premorphine levels. Choice of a
smaller dose of remifentanil remained at
premorphine levels (near-zero) for Monkey
3506.
Premorphine response rates reflected pref-
erence: The remifentanil-preferring monkeys
responded more rapidly for remifentanil
compared to cocaine (Monkey 2084 respond-
ed just slightly faster for remifentanil) whereas
the cocaine-preferring monkey (3506) re-
sponded more rapidly for cocaine than for
remifentanil (right panels, Figure 1). Re-
sponse rates maintained by cocaine increased
3 hr following morphine administration for
Monkeys 3956, 2084, and 3506, although rates
eventually returned to premorphine levels for
Monkey 2084 by the time stable behavior was
observed. Rates of remifentanil-maintained
responding decreased, with the exception of
Monkey 3506 whose rates generally did not
change relative to premorphine rates. This
likely was due to a floor effect that resulted
from the low dose of remifentanil self-admin-
istered by this monkey during the assessment
of choice.
Figure 2 shows choice of remifentanil and
response rates for remifentanil and cocaine in
the sessions that occurred 20.5 hr following
each morphine injection. Choice of remifen-
tanil (relative to cocaine) increased for all
monkeys with the exception of Monkey 3953,
whose preference for remifentanil remained
unchanged relative to premorphine. Whereas
Monkey 3506 did not develop a preference for
remifentanil as the result of daily morphine
exposure, he did consume more remifentanil
than in the premorphine condition (during
which he chose cocaine almost exclusively).
Response rates for remifentanil increased over
the course of morphine administration for
Monkeys 3956, 2084, and 3506. Concurrently,
rates of responding for cocaine decreased for
Monkeys 3956 and 2084. Monkey 3953’s rates
did not change appreciably for either drug.
Following evaluation of demand (results
below), daily morphine injections were discon-
tinued and the remaining monkeys were again
allowed to choose between cocaine and
remifentanil. The number of injections of
each drug in stable postmorphine choice
sessions is shown in Table 2. For the most
part the pattern of choice returned to pre-
morphine levels. The number of overall
injections increased slightly for Monkey 2084,
whereas the number of cocaine injections was
elevated relative to previous conditions for
Monkey 3953 and remained low relative to
premorphine conditions for Monkey 3506.
Demand
For each monkey and time point, the mean
numbers of infusions earned at each response
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requirement are shown in Tables 3 (cocaine)
and 4 (remifentanil). Shown in parentheses
are the average response rates (responses/s).
Figure 3 shows the group mean number of
cocaine (top panel) and remifentanil (bottom
panel) infusions earned as a function of the
response requirement on a log–log scale at
each time point.
For each drug, the exponential demand
equation (Hursh & Silberberg, 2008) then was
fitted separately to the data from each time
point. Obtained a, Q0, and goodness-of-fit (R
2)
values are shown in the Group section of
Table 5. Also shown in Table 5 are the same
parameters obtained when the exponential
demand equation was fitted to the individual
subject infusion data for each drug and time
point. With respect to cocaine demand, the Q0
parameter—representing an estimate of con-
sumption at zero-price—was higher for each
monkey in the 20.5-hr and postmorphine time
periods relative to the premorphine period.
The Q0 parameter also was higher in the 3-hr
period relative to the premorphine period for
3 of 4 monkeys. With respect to the a
parameter, for each monkey the postmor-
phine demand curve was more inelastic than
the premorphine demand curve, as indicated
by lower a values. In 3 of 4 monkeys, demand
curves obtained at the 20.5-hr time points also
Fig. 1. Choice between a dose of remifentanil and a dose of cocaine 3 hr after daily administration of 3.2 mg/kg/inj
morphine in 4 rhesus monkeys. Percent choice of remifentanil is shown on the left ordinate and rates of responding
maintained by the doses of remifentanil and cocaine are shown on the right ordinate. The initial data point and the
horizontal dashed line represent premorphine choice; the error bars are standard deviations. Daily sessions are shown on
the abscissa. Note that the dose of remifentanil is 0.03 mg/kg/inj for Monkey 3506 (bottom) and 0.3 mg/kg/inj for the
other monkeys.
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were more inelastic relative to the premor-
phine curves. Demand elasticity 3-hr postmor-
phine resembled that obtained premorphine.
Examination of the individual subject data
in Table 5 also shows that with respect to
remifentanil demand, the Q0 parameter was
lower for each monkey at the 3-hr time period
relative to the premorphine period. In addi-
tion, 3 of 4 monkeys exhibited enhanced Q0
parameters 20.5 hr after a morphine injection
relative to the premorphine demand curve.
The Q0 parameter obtained postmorphine was
slightly lower than that obtained premorphine
for each monkey.
Relative to the premorphine demand curve,
the remifentanil demand curve obtained at the
3-hr time period was more elastic (higher a
values) for each monkey. Three of four
monkeys exhibited less elastic demand func-
tions 20.5 hr after a morphine injection
relative to that obtained premorphine. Finally,
2 of 3 monkeys continued to exhibit less elastic
demand functions during the postmorphine
determination relative to the premorphine
determination.
Figure 4 shows the group demand curves for
cocaine and remifentanil at each time period.
These demand curves are the same curves as
presented in Figure 3, but here they are
grouped by time period for the purposes of
additional comparisons. In the premorphine
baseline, cocaine demand was more elastic
Fig. 2. Choice between a dose of remifentanil and a dose of cocaine 20.5 hr after daily administration of 3.2 mg/kg/
inj morphine in 4 rhesus monkeys. Percent choice of remifentanil is shown on the left ordinate and rates of responding
maintained by the doses of remifentanil and cocaine are shown on the right ordinate. The initial data point and the
horizontal dashed line represent premorphine choice; the error bars are standard deviations. Daily sessions are shown on
the abscissa. Note that the dose of remifentanil is 0.03 mg/kg/inj for Monkey 3506 (bottom) and 0.3 mg/kg/inj for the
other monkeys.
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Table 3
The average number of infusions and response rate (responses/s; shown in parentheses)
associated with demand for cocaine prior to daily morphine (Pre), 3 and 20.5 hr following each
morphine injection during daily morphine, and 4 to 5 weeks following daily morphine (Post).
Monkey FR Pre 3 hr 20.5 hr Post
3956 10 74 (3.2) 92 (5.6) 81 (1.3) –
32 41 (3.0) 69 (5.6) 90 (5.4) –
100 22 (2.8) 20 (5.4) 49 (5.8) –
320 2 (1.6) 1 (5.6) 9 (6.2) –
562 0 (1.2) 0 (3.6) 0 (3.1) –
1000 0 (0.9) 0 (4.0) 0 (5.2) –
3953 10 80 (1.8) 96 (1.4) 99 (1.3) 115 (2.0)
32 46 (2.3) 67 (1.7) 78 (1.4) 99 (2.3)
100 34 (2.5) 27 (1.1) 29 (1.8) 38 (2.4)
320 16 (1.8) 2 (0.3) 10 (2.2) 11 (2.3)
562 5 (1.4) 0 (0.1) 2 (2.6) 7 (2.6)
1000 0 (0.7) 0 (0.1) 0 (1.2) 1 (1.0)
2084 10 87 (1.5) 47 (1.9) 111 (1.7) 112 (2.4)
32 79 (1.8) 33 (2.3) 109 (4.2) 91 (3.9)
100 48 (2.8) 24 (1.6) 93 (5.2) 70 (4.6)
320 14 (2.3) 23 (2.2) 54 (4.6) 23 (4.3)
562 2 (1.3) 2 (1.0) 32 (4.2) 17 (4.6)
1000 0 (0.6) 8 (1.6) 16 (4.6) 2 (5.6)
3506 10 62 (2.2) 57 (1.5) 60 (1.0) 88 (1.1)
32 44 (2.4) 44 (2.6) 71 (1.6) 67 (1.5)
100 27 (2.1) 43 (1.7) 37 (2.4) 38 (2.1)
320 12 (2.4) 0 (1.5) 23 (2.8) 22 (2.8)
562 7 (2.4) 0 (0.9) 11 (3.2) 6 (2.5)
1000 1 (2.1) 0 (1.0) 4 (2.8) 1 (1.6)
Table 4
The average number of infusions and response rate (responses/s; shown in parentheses)
associated with demand for remifentanil prior to daily morphine (Pre), 3 and 20.5 hr following
each morphine injection during daily morphine, and 4 to 5 weeks following daily
morphine (Post).
Monkey FR Pre 3 hr 20.5 hr Post
3956 10 85 (3.8) 17 (3.3) 91 (4.2) –
32 51 (3.7) 2 (2.8) 72 (5.0) –
100 17 (3.5) 0 (4.0) 38 (6.0) –
320 4 (3.3) 0 (2.4) 5 (5.9) –
562 2 (2.9) 0 (4.4) 0 (4.1) –
1000 0 (2.4) 0 (4.6) 0 (2.1) –
3953 10 92 (0.7) 30 (0.2) 68 (0.6) 92 (0.8)
32 72 (1.2) 28 (0.4) 64 (1.1) 59 (0.7)
100 43 (1.5) 5 (0.3) 36 (1.4) 33 (0.9)
320 17 (1.9) 0 (0.2) 17 (3.1) 13 (1.5)
562 8 (2.2) 0 (0.0) 3 (2.6) 7 (2.2)
1000 3 (1.6) 0 (0.0) 1 (3.1) 3 (2.6)
2084 10 76 (0.7) 65 (0.2) 95 (0.7) 84 (0.5)
32 67 (1.3) 46 (0.4) 89 (1.5) 74 (0.9)
100 46 (1.9) 31 (0.7) 72 (2.5) 53 (1.5)
320 20 (2.7) 9 (0.8) 44 (4.0) 31 (2.8)
562 7 (3.2) 8 (1.0) 30 (3.9) 23 (3.2)
1000 2 (2.7) 0 (0.4) 4 (2.5) 13 (3.7)
3506 10 73 (1.4) 30 (0.8) 99 (2.2) 66 (1.9)
32 58 (1.5) 17 (0.8) 87 (2.3) 57 (2.1)
100 31 (2.4) 4 (1.4) 65 (2.7) 42 (2.0)
320 14 (2.7) 4 (0.5) 35 (3.0) 23 (2.4)
562 6 (2.7) 0 (0.0) 21 (3.1) 13 (2.3)
1000 2 (2.7) 0 (3.3) 7 (3.7) 5 (2.8)
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(higher a values) than remifentanil demand
for each. There were no consistent differences
in the Q0 parameter between cocaine and
remifentanil at this time point.
Three hours after a morphine injection, the
relative elasticity of cocaine and remifentanil
reversed. During this period, remifentanil
demand was more elastic than cocaine de-
mand for each monkey. In addition, for 3 of 4
monkeys, the Q0 value associated with the
cocaine demand curve was higher than that
associated with the remifentanil demand
curve.
At 20.5 hr after a morphine injection and
during the postmorphine determination, the
Q0 parameter associated with cocaine usually
was higher than that of remifentanil for each
monkey except Monkey 3506 (20.5-hr period).
There were no consistent between-drug differ-
ences in a at the 20.5-hr time point. Similar to
the premorphine period, cocaine demand was
more elastic than remifentanil demand in 2 of
3 monkeys during the postmorphine determi-
nation.
DISCUSSION
The present study investigated two methods
for measuring changes in the reinforcing
effectiveness of remifentanil in opioid-depen-
dent monkeys. The first allowed monkeys to
choose between remifentanil and cocaine. The
second reflected changes in demand for both
drugs. Using both procedures, there was some
evidence that the reinforcing effect of remi-
fentanil was enhanced during withdrawal
(20.5 hr after a morphine injection). First,
monkeys exhibited increased choice of remi-
fentanil over cocaine in the choice procedure
during this time. In addition, for 3 of 4
monkeys, demand became more inelastic
(lower a values) and the initial level of demand
(Q0) increased. Interestingly, demand for
cocaine also tended to increase during mor-
phine withdrawal, as illustrated by lower a
values and higher Q0 values in most monkeys
(3 of 4 and 4 of 4, respectively).
The results from the choice and demand
procedures are mostly congruent. In the
premorphine baseline, the 3 monkeys self-
administering 0.3 mg/kg/infusion remifenta-
nil preferred remifentanil to cocaine. For
these monkeys, demand for remifentanil also
was more inelastic relative to cocaine. Three
hours after a morphine injection, 2 of the 3
monkeys self-administering 0.3 mg/kg/infu-
sion remifentanil (Monkey 3953 being the
exception) showed individual patterns of
choice that generally indicated a decrease in
the relative reinforcing effects of remifentanil
or an increase in the relative reinforcing
effects of cocaine. Parallel results are seen in
the demand curves obtained at this time point;
demand for remifentanil became more elastic
relative to cocaine. A selective decrease in
opioid self-administration engendered by opi-
oid administration has been demonstrated in
monkeys responding for food or drug in other
situations (e.g., Mello, Bree, & Mendelson,
1983; Winger & Woods, 2001) and may be a
general effect of this drug class. An exception
to this general pattern are the choice results
from Monkey 3953. For this monkey, choice
appeared quite insensitive to the effects of
Fig. 3. Group demand curves for cocaine (top) and
remifentanil (bottom) prior to morphine administration
(closed circles, solid lines), 3 hr after daily morphine
(open triangles, dashed lines), 20.5 hr after daily
morphine (closed squares, dotted lines), and 4 to 5 weeks
following termination of daily morphine (open squares,
dotted-dashed lines). Data points represent the group
means.
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morphine either 3 hr or 20.5 hr following its
administration. Despite minimal effects on
choice, following morphine administration,
demand for remifentanil appeared to be more
suppressed than demand for cocaine in this
monkey, as indexed by lower Q0 values and
higher a values.
When monkeys were displaying signs of mild
opioid withdrawal, all monkeys except Monkey
3953 showed a gradually increasing choice of
Table 5
Parameters describing demand for cocaine and remifentanil in conditions prior to daily
morphine injections (Pre), 3 and 20.5 hr following each morphine injection during daily
morphine, and 4 to 5 weeks following daily morphine (Post). The Group parameters correspond
to the demand curves shown in Figures 3 and 4.
Monkey Measure
Cocaine Remifentanil
Pre 3 hr 20.5 hr Post Pre 3 hr 20.5 hr Post
3956 Q0 85.8 121.2 132.6 — 70.7 57.6 123.6 —
a 3.62E-5 3.30E-5 2.03E-5 — 2.47E-5 3.78E-4 2.37E-5 —
R2 .94 .97 .83 — .95 .99 .88 —
3953 Q0 80.4 121.0 100.6 106.6 79.8 55.5 77.1 66.6
a 1.69E-5 2.86E-5 1.75E-5 1.01E-5 8.67E-6 9.73E-5 1.30E-5 1.00E-5
R2 .87 .94 .94 .97 .98 .96 .98 .96
2084 Q0 109.5 35.2 114.6 116.7 79.7 69.6 109.9 73.1
a 1.57E-5 1.15E-5 3.01E-6 6.64E-6 9.50E-6 1.84E-5 4.91E-6 4.26E-6
R2 .92 .54 .99 .96 .99 .84 .93 .96
3506 Q0 56.0 104.8 64.5 88.0 63.9 26.1 96.2 62.4
a 1.40E-5 4.85E-5 8.07E-6 1.06E-5 1.14E-5 1.50E-5 4.89E-6 7.39E-6
R2 .97 .81 .98 .98 .99 .84 .99 .99
Group Q0 78.8 72.1 85.6 104.1 78.1 32.9 89.7 66.3
a 1.65E-5 1.81E-5 6.67E-6 8.58E-6 1.06E-5 3.99E-5 7.14E-6 6.42E-6
R2 .96 .79 .99 .98 1.00 .94 .99 .97
Fig. 4. Group demand curves for cocaine (closed circles, solid lines) and remifentanil (open squares, dotted lines) at
each time point. Data points represent the group means.
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remifentanil 20.5 hr following daily morphine
injections. Interestingly, Monkey 3953 was the
only monkey for whom demand for remifen-
tanil became more elastic (relative to the
premorphine period). Thus, in 3 of 4 mon-
keys, both measures of the reinforcing effects
of remifentanil indicated that remifentanil
became a better reinforcer relative to cocaine
during mild opioid withdrawal. In addition,
demand for cocaine also increased (lower a
values and higher Q0 values) relative to
cocaine demand prior to morphine exposure.
The finding that cocaine demand increased
during morphine withdrawal might be unex-
pected, particularly because choice for cocaine
over remifentanil was decreased at this time.
However, it is consistent with the finding of
Gerak et al. (2009) that responding main-
tained by small doses of cocaine was increased
17 hr following the discontinuation of mor-
phine. In the context in which it is the only
drug available, it is possible that cocaine
becomes a better reinforcer during opioid
withdrawal than it is in the absence of
withdrawal. Indeed, previous research in our
laboratory has demonstrated that cocaine and
remifentanil are economic substitutes (Wade-
Galuska et al., 2007). As such, operations that
increase the reinforcing effectiveness of remi-
fentanil also should increase the reinforcing
effectiveness of cocaine. Cocaine, however,
appears to be an imperfect substitute for
remifentanil. When remifentanil was concur-
rently available in the choice procedure, the
relative reinforcing effectiveness of cocaine
was lower than that of the opioid.
It is also possible that the increase in cocaine
demand during opioid withdrawal could be
attributed to the conditioned reinforcing
functions of the stimuli associated with drug
infusions. Although the discriminative light
stimuli for cocaine and remifentanil availabil-
ity were different in color, the light that
accompanied infusions of both drugs was the
same color and location. Therefore, observed
demand for cocaine during morphine with-
drawal could be, at least in part, demand for
the stimuli previously paired with remifentanil.
Demand for stimuli paired with drug rein-
forcers has not been evaluated explicitly,
although such measurement might be helpful
as a quantitative index of drug craving (Weiss,
2005). In the current situation where there is a
confound between cocaine delivery and stim-
uli paired with remifentanil delivery, the
precise nature of the stimuli maintaining
behavior cannot be specified. Nevertheless,
the data indicate that polydrug abusers may
show increased intake of a stimulant during
opioid withdrawal, particularly when the set-
ting conditions for administration of the two
drugs are similar.
One difficulty with comparing drugs in a
choice paradigm is that preference depends
on the dose of each drug compared. The doses
of cocaine and remifentanil used here were
chosen on the basis of previous research
(Wade-Galuska et al., 2007) showing that they
resulted in comparable levels of responding in
the context of a demand procedure. Prior to
the start of daily morphine administration it
would have been ideal for the monkeys to
respond about equally for both drugs, provid-
ing a baseline that could easily detect increases
or decreases in preference for either drug as
the result of morphine exposure. In the
present study, however, preference for remi-
fentanil was observed for 3 of the 4 monkeys,
with choice being nearly exclusive for two of
them. The fourth monkey showed a prefer-
ence for cocaine due to the fact that a smaller
dose of remifentanil was used. It is likely that
exclusive or nearly exclusive choice for one of
the drugs was demonstrated because an FR
schedule of reinforcement was used. FR
schedules tend to favor exclusive preference
for the alternative that is available at a cheaper
price or that is more favorable. For this reason
it is unlikely that any doses would have
resulted in indifference between these drugs.
While the results from the choice and
demand assays are mostly congruent, in some
respects it appears as if the choice procedure
may be better at revealing differences in the
reinforcing effects of drugs than the analysis of
demand. Consider that there was no consistent
difference between the Q0 parameter between
drugs during the premorphine baseline. At the
smallest price investigated (FR 10), consump-
tion of the two drugs was comparable. Never-
theless, at the same price, near-exclusive
preference was obtained for remifentanil. In
addition, choice of remifentanil increased
relative to cocaine at the 20.5-hr time point,
but elasticity of demand for both drugs at this
time point were virtually identical (Figure 4,
lower left). Thus, it appears that the choice
procedure appears to be exquisitely sensitive
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to the relative reinforcing effectiveness of the
two drugs. Nevertheless, choice procedures do
not provide a measure of absolute reinforcing
effectiveness. According to Hursh and Silber-
berg (2008), measures of demand eliminate
the influence of alternatives on the consump-
tion of a commodity and therefore provide a
more absolute measure of what they refer to as
essential value. In the case of choice and
demand at the 20.5-hr time point, while the
relative reinforcing value of remifentanil was
increased, the absolute reinforcing value of
cocaine also increased, probably due to its
substitutability with remifentanil. Thus, inves-
tigating both choice and demand provides a
more complete picture of how morphine
withdrawal modulates the reinforcing value
of these two drugs than either measure alone.
The changes in demand for remifentanil
and the changes in preference for remifenta-
nil were not large in this study. This was
perhaps due to the fact that the dose of
morphine given daily, 3.2 mg/kg/day, was
fairly small. Although this dose is sufficient to
produce opioid receptor antagonist-generated
withdrawal-induced discriminative-stimulus ef-
fects in monkeys (France & Woods, 1989) and
tolerance to the reinforcing effects of low
efficacy agonists (Winger & Woods, 2001), the
withdrawal signs produced by the termination
of the morphine dose in the present study
were small relative to those produced by large
doses of heroin or morphine administered in
some previous studies (Negus, 2006; Griffiths
et al. 1981; Gerak et al. 2009). A larger dose of
morphine, or twice-daily administration of the
current dose, would have produced much
more intense withdrawal signs that likely
would have magnified the relatively small
changes in choice and demand that were
observed in this study. Nevertheless, it is
interesting and important to observe that
changes in preference for an opioid can occur
even under conditions of very mild opioid
withdrawal.
Following the conclusion of morphine
injections, choice of remifentanil and cocaine
approximated what was observed prior to
morphine administration. However, demand
for cocaine and remifentanil remained inelas-
tic relative to the premorphine condition in
most cases (the results of remifentanil demand
for Monkey 3953 is the only exception). This
suggests the possibility that withdrawal-associ-
ated increases in the reinforcing effectiveness
of these drugs lasted beyond (in this case 4 to
5 weeks after) the period of dependence.
Prolonged withdrawal has been observed using
cardiovascular measures in rhesus monkeys up
to 3 weeks after discontinuation of 5.6 mg/kg
morphine twice daily (Becker, Gerak, Koek, &
France, 2008). Gerak et al. (2009) reported
increases in responding by rhesus monkeys for
very small doses of heroin up to 10 weeks after
withdrawal of 10 mg/kg morphine twice daily,
and Zhou et al. (2004) noted increased
responding for the stimuli previously associat-
ed with heroin in rats 4 weeks after heroin self-
administration was discontinued.
Unfortunately, in this study it was not
possible to determine if the long-term changes
in elasticity observed are due solely to the mor-
phine regimen. The results are confounded
by a history of continued drug self-administra-
tion. Christensen, Silberberg, Hursh, Roma,
and Riley (2008) demonstrated that rats’
demand for cocaine became more inelastic
simply by providing a continued history of
cocaine self-administration. Nevertheless, if
the reinforcing effectiveness of an opioid
drug is enhanced even when physical symp-
toms of withdrawal are no longer apparent—
for whatever reason—this may contribute
to relapse in recovering dependent individu-
als. It is worth determining whether a similar
enhancement of the reinforcing effectiveness
of stimulants, which produce little or no
physical withdrawal, occurs following adminis-
tration of large doses of drugs of the stimulant
class.
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